PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: SOAR Communications

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Coherex Medical Closes $16.5 Million Series B Preferred Stock Financing - Tullis Health Investors and a strategic investor join prior investors, vSpring Capital and Oxford Bioscience Partners, in Coherex’ Series B Preferred Stock financing round
Coherex Medical Closes $16.5 Million Series B Preferred Stock Financing

 

NewswireToday - /newswire/ - Salt Lake City, UT, United States, 2009/08/21 - Tullis Health Investors and a strategic investor join prior investors, vSpring Capital and Oxford Bioscience Partners, in Coherex’ Series B Preferred Stock financing round.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Coherex Medical, Inc. today announced that it has closed a $16.5 million Series B Preferred Stock financing. After the close of this investment, Coherex has now raised nearly $28.0 million in equity financing from outside funding sources since inception.

vSpring Capital and Oxford Bioscience Partners were co-lead investors on this financing, and both venture capital firms participated in Coherex’ prior Series A Preferred Stock financing. Also joining vSpring and Oxford in Coherex’ Series B financing were Tullis Health Investors, a leading venture capital firm focused on the healthcare industry, and a strategic investor.

“I am pleased to announce today that Coherex Medical™ has closed its Series B financing, particularly given today’s challenging economic times,” said Richard J. Linder, Coherex president and CEO. “This is a solid example of the quality of the Coherex team and our success in developing the Coherex FlatStent™ EF PFO Closure System, a technology that represents a significant advancement in the treatment and repair of patent foramen ovale, a common heart defect.”

Coherex announced in June that the Coherex FlatStent EF was the first “in-tunnel” device to receive CE Mark clearance for closing Patent Foramen Ovale (PFO), a heart defect found in approximately 20 percent of the worldwide population.

“We believe that PFO closure represents a significant market opportunity, and we are confident that Coherex Medical has developed the next generation device for PFO closure with its Coherex FlatStent,” said Dinesh Patel, Ph.D., vSpring managing partner and Coherex board member. “In addition, we believe Coherex is establishing itself as a leading structural heart company, and as a result, we are excited to invest again in Coherex, its technologies and its people.”

“Coherex Medical is one of the most promising medical device companies we have found in the world,” said Jeff Barnes, general partner of Oxford Bioscience Partners and Coherex board member. “Not only does Coherex have superior technology addressing substantial market opportunities, its senior executives have been down this path before. They’ve designed innovative medical devices, navigated the regulatory process, and taken products to the marketplace. We believe that the combination of a talented and experienced management team coupled with world class technology almost always leads to market success.”

About Patent Foramen Ovale (PFO) Heart Defects
A foramen ovale is a tunnel-like opening between the upper chambers of the heart that allows blood to bypass the lungs while a fetus is in the womb. Normally, the foramen ovale closes soon after an infant is born. However, if this opening fails to close naturally after birth, the opening is said to remain patent and the condition is called a patent foramen ovale (PFO) – a common heart defect that occurs in approximately 20 percent of the population.

Under certain conditions, a PFO may allow blood to bypass the lungs and shunt directly from the right side of the heart to the left. Since the lungs normally filter all blood flowing through the body, such shunting may allow unfiltered blood clots and other components to travel directly to the brain or other regions of the body.

About Coherex Medical
Formed in 2003, Coherex Medical (coherex.com) is focused on addressing structural heart disease and conditions through the development of innovative medical devices. For more information, please call 801-433-9900.

About Oxford Bioscience Partners
Oxford Bioscience Partners is one of the largest venture capital firms focused exclusively in the life science sectors. With approximately $1 Billion under management and 13 investment professionals, Oxford has invested in and provided management assistance to well over 100 start-up, early and mid-stage companies.

About vSpring Capital
vSpring Capital is an early-stage venture capital firm with approximately $400 million under management. With offices in Utah and New Mexico, vSpring invests in information technology and life science companies that have the potential to transform their markets and create lasting value.

About Tullis Health Investors
Tullis Health Investors provides venture capital to small and mid-sized health care companies at all stages of growth. Based in Stamford, Connecticut, the firm was founded in 1986 and has raised four health care focused venture capital funds. For more information on Tullis Health Investors and its portfolio companies, please visit the firm's Website.

Coherex Medical and Coherex FlatStent are trademarks of Coherex Medical, Inc. All other trademarks are the properties of their respective owners.

Coherex Medical Contacts:
Trent Loveless, Coherex Medical, 801-433-9900, tloveless[.]coherex.com

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: SOAR Communications

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Coherex Medical Closes $16.5 Million Series B Preferred Stock Financing

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: David Politis 
801-523-3730 dpolitis[.]politis.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any SOAR Communications securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From SOAR Communications / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove
GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration
Insulin Delivery Devices Market Size to Expand at 7% CAGR through 2020 Says PMR
Intubation Market Significant Profits Estimated to be Generated by 2025 Says Persistence Market Research
PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow Ltd

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)